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ABSTRACT
Although rare, gastrointestinal posttransplant lymphoproliferative disorder (PTLD) can lead to abdominal pain or
gastrointestinal bleeding in patients with a history of solid-organ transplantation. We describe a case of isolated
gastrointestinal PTLD in a patient who presented with acute on chronic iron deficiency anemia 26 years after
heart transplant. A comprehensive endoscopic evaluation with video capsule endoscopy and small bowel entero-
scopy revealed a large cratered ulceration in the small bowel with abnormal mucosal changes, which led to the
diagnosis of PTLD.
INTRODUCTION
Iron deficiency anemia and gastrointestinal (GI) bleeding are frequently seen among patients with multiple cardiac
comorbidities, including valvular heart disease, cardiomyopathies, and cardiogenic shock. While common etiolo-
gies of bleeding include angioectasias, ulcers, and ischemic injury, neoplastic processes, including posttransplant
lymphoproliferative disorder (PTLD), are an important consideration in patients who have undergone solid organ
transplantation. PTLD is the most common malignancy among transplant patients, comprising 25% of all posttrans-
plant malignancies. GI-isolated PTLD is an uncommon presentation and may present with abdominal pain or
bleeding.
CASE REPORT
A 65-year-old man with a history of orthotopic heart transplant 26 years prior and chronic immunosuppression with
cyclosporine, azathioprine, and prednisone presented to the hospital with dyspnea on exertion. His additional
comorbidities included severe aortic stenosis and heart failure of the transplanted heart, as well as paroxysmal
atrial fibrillation (on warfarin) and chronic kidney disease. He was found to be anemic with hemoglobin 7.5 g/dL,
compared to 11.0 g/dL 6 months prior, so the inpatient gastroenterology team was consulted. Colonoscopy
revealed internal hemorrhoids, non-bleeding colonic diverticuli, and several small polyps, which were removed.
Upper endoscopy revealed a superficial clean-based gastric ulcer in the body and a few small antral erosions, which
were felt to be the source of his anemia. Biopsies of the stomach revealed only reactive gastropathy and chronic
inflammation. He was started on a proton-pump inhibitor twice daily and discharged home.
Two weeks following discharge, he presented again, this time with mixed cardiogenic and septic shock due to pneu-
monia, which resolved with broad-spectrum antibiotics. His labs were notable for hemoglobin as low as 6.0 g/dL, iron
34 mg/dL, and ferritin 21 ng/mL, consistent with iron-deficiency anemia. At this time, the patient reported solid
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black stools, which were his baseline since starting oral iron
supplementation a year prior. Given his worsening anemia,
computed tomography with GI bleeding protocol was con-
sidered, but this was deferred given the patient’s advanced
renal disease. He underwent video capsule endoscopy,
which revealed areas of ulceration with heaped up mucosa
and active bleeding in the small bowel (Figure 1). These
ulcers were thought to be due to ischemic injury in the set-
ting of recent septic shock and the patient’s known severe
atherosclerotic vascular disease. His anemia persisted de-
spite repeated transfusions. Magnetic resonance entero-
scopy did not reveal any obvious intraluminal masses or
lesions. Subsequently, a small bowel enteroscopy with a pe-
diatric colonoscope revealed a large cratered ulcer with an
adherent clot in the distal duodenum, surrounded by edem-
atous and irregular mucosa (Figure 2). Biopsies of the ulcer
edge revealed monomorphic posttransplant lymphoproli-
ferative disorder (PTLD), plasmacytoma-like (Figure 3). Serum
Epstein-Barr virus (EBV) polymerase chain reaction remained
undetectable. Staging positron emission tomography–com-
puted tomography demonstrated enhancement only in the the
small intestine, and there was no evidence of PTLD on bone
marrow biopsy. The patient’s chronic immunosuppression regi-
men was decreased, and he was initiated on rituximab prior to
hospital discharge.
DISCUSSION
The rates of PTLD vary by transplant type; 1–6% in heart
transplants, 1–3% in kidney or liver transplants, 4–10% in lung
transplants, and in up to 20% in small intestine transplants.1
The average time between transplant and diagnosis is
approximately 5.5 years, although early cases can develop
during the first year after transplant. Most commonly,
patients present with fever and lymphadenopathy; however,
extranodal involvement will be present in two-thirds of cases.
As the majority of these disorders are associated with EBV,
EBV seroconversion is an important risk factor for developing
PTLD. EBV-negative recipients who are transplanted an
organ from an EBV-positive donor are at a particularly high
risk for PTLD.2 Male gender, white race, and younger age at
transplantation are additional independent risk factors for
developing PTLD.1,3 Lastly, there is a known correlation
between type and duration of immunosuppression and the
risk of developing PTLD. Therefore, reduction in immunosup-
pression is the first step in treating PTLD; 25–63% of adults
will respond to reduction in immunosuppression alone.4
Chemotherapy, anti-B-cell antibodies, or cytokine-based
therapies may be used in addition to reduction of immuno-
suppression for systemic treatment of PTLD.
Figure 2. Small bowel enteroscopy showing a deep, cratered ulcer with
an adherent clot in the distal duodenum.
Figure 3. (A) High-power field of small bowel biopsies demonstrating
numerous atypical plasma cells with irregular nuclear contours and prom-
inent nucleoli. (B) Diffuse staining for k light chain in the plasma cells of
the lamina propria, consistent with a clonal process.
Figure 1. Video capsule endoscopy demonstrating multiple areas of
ulceration within the small bowel.
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Studies demonstrate that up to half of patients with PTLD
have evidence of disease in the small bowel, colon, or mesen-
teric lymph nodes.5,6 However, isolated PTLD of the GI tract
is rare. As PTLD is more common among pediatric patients,
isolated GI PTLD is best described in pediatric literature.
O’Connor et al. described 6 cases diagnosed in children after
liver transplant who were suspected to have PTLD given
symptoms such as anemia, failure to thrive, vomiting, or ab-
dominal pain. The colon and stomach were the most common
sites involved, with rubbery, raised, and ulcerated lesions
seen on endoscopy.7 Additional pediatric case reports
describe GI bleeding as the presenting symptom leading to
endoscopic diagnosis of PTLD with ulcerations in the small
intestine.8,9 Among adults, the only case series of isolated GI
PTLD described 12 cases in lung-transplant patients. Of these,
7 cases involved the colon and 5 cases involved the small
bowel. Presenting symptoms included abdominal pain, consti-
pation, and hematochezia. The median time to presentation
after transplant was 2.9 years, and most demonstrated ulcera-
tion and/or perforation on endoscopy.10 There are very few
additional reports of isolated PTLD of the GI tract in the adult
transplant population.6,11
Our case represents a rare endoscopic diagnosis of isolated
PTLD of the small intestine in a patient presenting with iron-
deficiency anemia without overt GI bleeding or abdominal
pain. This case is particularly unique as it represents a diagno-
sis of PTLD more than 25 years after solid-organ transplanta-
tion. Though less common than other causes of iron-
deficiency anemia in patients with valvular heart disease or
cardiomyopathies, such as Heydes syndrome, angioectasias,
and ischemia, PTLD must be considered in posttransplant
patients presenting with GI bleeding, ulcers, or perforation.
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